PubRank

Gavin Lambert

Author PubWeight™ 63.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 2003 3.29
2 Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006 2.41
3 Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010 2.01
4 Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007 1.90
5 Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 2011 1.80
6 Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 2005 1.80
7 Autonomic control of the heart and renal vascular bed during autonomic dysreflexia in high spinal cord injury. Clin Auton Res 2002 1.75
8 Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009 1.60
9 Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress 2007 1.52
10 Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA 2012 1.50
11 Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion. J Hypertens 2004 1.46
12 Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 2002 1.46
13 Angiotensin II and norepinephrine release: interaction and effects on the heart. J Hypertens 2005 1.44
14 Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol 2011 1.22
15 Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol 2008 1.21
16 Relation between QT interval variability and cardiac sympathetic activity in hypertension. Am J Physiol Heart Circ Physiol 2011 1.15
17 Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med 2006 1.13
18 Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007 1.12
19 Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med 2006 1.10
20 Blood pressure and sympathetic nervous system response to renal denervation. Hypertension 2012 1.08
21 Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol 2008 1.02
22 Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens 2012 1.00
23 Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans. J Physiol 2009 0.97
24 Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease. J Physiol 2012 0.96
25 Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One 2013 0.96
26 The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am J Physiol Regul Integr Comp Physiol 2002 0.95
27 The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol 2006 0.94
28 Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile. Hypertension 2009 0.94
29 Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 2010 0.94
30 Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension 2011 0.93
31 Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol 2012 0.92
32 Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Ann N Y Acad Sci 2004 0.89
33 Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation. Am J Physiol Heart Circ Physiol 2005 0.88
34 Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann N Y Acad Sci 2008 0.87
35 Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress. Biogerontology 2002 0.87
36 Cardiac response to norepinephrine and sympathetic nerve stimulation following experimental subarachnoid hemorrhage. J Neurol Sci 2002 0.87
37 Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol 2012 0.86
38 European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? J Hypertens 2010 0.86
39 Cardiovascular actions of the venom from the Irukandji (Carukia barnesi) jellyfish: effects in human, rat and guinea-pig tissues in vitro and in pigs in vitro. Clin Exp Pharmacol Physiol 2005 0.86
40 Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. J Physiol 2005 0.86
41 Advances in sympathetic nerve recording in humans. Front Physiol 2012 0.86
42 Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol 2008 0.85
43 Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 2012 0.83
44 Stress reactivity and its association with increased cardiovascular risk: a role for the sympathetic nervous system? Hypertension 2010 0.82
45 Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab 2004 0.82
46 Reduced spontaneous baroreceptor sensitivity in patients with renovascular hypertension. J Hypertens 2002 0.81
47 Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity. Int J Cardiol 2013 0.81
48 Histone modifications regulate the norepinephrine transporter gene. Cell Cycle 2010 0.81
49 Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clin Neurophysiol 2010 0.80
50 Chronic placental insufficiency affects retinal development in the guinea pig. Invest Ophthalmol Vis Sci 2004 0.80
51 Regional sympathetic effects of low-dose clonidine in heart failure. Hypertension 2003 0.80
52 Influence of leptin on neurotransmitter overflow from the rat brain in vitro. Regul Pept 2002 0.79
53 Morning surge in blood pressure is associated with reactivity of the sympathetic nervous system. Am J Hypertens 2014 0.79
54 NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro. Regul Pept 2004 0.77
55 Depression and blood pressure control: All antidepressants are not the same. Hypertension 2009 0.77
56 Cardiac autonomic function in adolescents operated by arterial switch surgery. Int J Cardiol 2013 0.76
57 Regional norepinephrine spillover in response to angiotensin-converting enzyme inhibition in healthy subjects. J Hypertens 2003 0.76
58 Indices of sympathetic activity and the paradox of chromogranin A. J Hypertens 2010 0.75
59 ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. J Hypertens 2016 0.75
60 OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION. J Hypertens 2016 0.75
61 OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION. J Hypertens 2016 0.75
62 ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. J Hypertens 2016 0.75
63 European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes. J Hypertens 2011 0.75
64 Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure. Eur J Heart Fail 2005 0.75